SCM
XENT

Sterling Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Sterling Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-23,583
Closed -$675K – 1047
2015
Q2 		$675K Hold
23,583
– – 0.01% 539
2015
Q1 		$609K Buy
+23,583
New +$539K 0.01% 586

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sterling Capital Management's XENT Position: Q3 2015 in Review

Sterling Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2015, closing a stake of 23,583 shares — an estimated $675K sold.

Sterling Capital Management first reported a position in XENT in Q1 2015 and held it in 2 quarters. The position peaked at $675K in Q2 2015. 125 funds tracked by Wall St. Rank hold XENT as of Q3 2015.

  • Sterling Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2015 after selling out during the quarter.
  • Sterling Capital Management sold 23,583 Intersect ENT, Inc shares in Q3 2015, an estimated $675K.
  • Sterling Capital Management first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 2 quarters.
  • Sterling Capital Management's Intersect ENT, Inc position peaked at $675K in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2015.

Based on Sterling Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.